Evidence-Based Approach Recommended for Acute Pancreatitis Management
MONDAY, March 18, 2024 -- In a clinical guideline issued by the American College of Gastroenterology and published online in the March issue of the American Journal of Gastroenterology, evidence-based recommendations are presented for the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2024 Category: Pharmaceuticals Source Type: news

Distinctive pathology associated with focal stenosis of the main pancreatic duct secondary to remote trauma: a long-term complication of seat belt pancreatitis - Wu AA, Thompson ED, Cameron JL, He J, Burkhart RA, Burns WR, Lafaro KJ, Shubert CR, Canto MI, Fishman EK, Hruban RH.
We present fou... (Source: SafetyLit)
Source: SafetyLit - March 16, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

TikTok Influencers Are Now Treating Ozempic Side Effects
Every day dozens of people come to Jennifer Witherspoon—a former dental office manager with zero medical training—for help managing nausea, headaches, and other side effects that can come with taking weight-loss shots. She even crafted a template response to help her quickly get through the messages. “People have offered to pay me, begged me to start a podcast, asked me to call their sisters-in-law, wanted me to call their doctor,” she said. “One lady even invited me to her wedding.” Even Oprah’s production company reached out to feature one of her videos in a prime time specia...
Source: TIME: Health - March 7, 2024 Category: Consumer Health News Authors: Madison Muller, Andre Tartar, and Tanaz Meghjani/Bloomberg Tags: Uncategorized healthscienceclimate wire Source Type: news

What do you know about pancreatitis?
Pancreatitis is inflammation of the pancreas, a long, flat gland that lies horizontally behind your stomach. The pancreas produces enzymes for digestion and hormones that regulate the way your body processes sugar. About 275,000 hospital stays for acute pancreatitis occur in the U.S. each year, according to the National Institute of Diabetes and Digestive and Kidney Disease. Chronic pancreatitis is less common, with about 86,000 hospital stays per year. And although pancreatitis is rare in children,… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 27, 2024 Category: Databases & Libraries Source Type: news

PET/CT scans show value in patients with rare type of pancreatitis
F-18 FDG-PET/CT scans may help predict relapses in patients with autoimmune pancreatitis, according to a study published January 17 in BMC Gastroenterology. In an analysis of F-18 FDG-PET/CT scans in patients with autoimmune pancreatitis (AIP) prior to treatment, specific imaging findings were higher in a group that subsequently relapsed than in those who did not relapse, noted first authors Shengxin Chen and Guanyun Wang, of Chinese PLA General Hospital in Beijing, and colleagues. “Relapse seriously affects the lives of patients and comprises a heavy psychological burden; therefore, it is necessary to identify predict...
Source: AuntMinnie.com Headlines - January 19, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Source Type: news

Professor gets $6.4M from U.S. DoD for acute pancreatitis research
Earlier this year, the professor was also awarded $2 million by the Department of Defense. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 4, 2024 Category: Pharmaceuticals Authors: Laurel Thrailkill Source Type: news

When Should We Consider A Rickettsial Disease?
Discussion Rickettsioses are “small, obligate intracellular, gram-negative, aerobic coccobacillary α-proeobacteria” from the genuses Rickettsia, Anaplasma, Coxiella, Ehrlichia, and Orientia genuses. Often they cause limited health problems but can cause severe disease and death. They present with a fever and other non-specific signs and symptoms, usually with a rash and lymphadenopathy. Other problems can include: Cardiac – endocarditis, myocarditis, pericarditis Gastrointestinal – abdominal pain, acute abdomen, cholecystitis, hepatitis, pancreatitis Heme/Lymph – hemophagocytosis, lymph...
Source: PediatricEducation.org - December 18, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Science ’s 2023 Breakthrough of the Year: Weight loss drugs with a real shot at fighting obesity
Show / hide sections navigation 2023 Breakthrough of the Year Runners-up Breakdowns Video Obesity plays out as a private struggle and a public health crisis. In the United States, about 70% of adults are affected by excess weight, and in Europe that number is more than half. The stigma against fat can be crushing; its risks, life-threatening. Defined as a body mass index of at least 30, obesity is thought to power type 2 diabetes, heart disease, arthritis, fatty liver disease, and certain cancers. Yet drug treatments...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news

Two Approaches for Infected Necrotizing Pancreatitis Go Head-to-Head
(MedPage Today) -- Upfront endoscopic necrosectomy may be suitable for certain patients with confirmed or suspected infected necrotizing pancreatitis, results of a small randomized trial suggested. In 70 patients undergoing drainage with endoscopic... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 24, 2023 Category: Gastroenterology Source Type: news

GI Adverse Events Increased With Use of GLP-1 Agonists for Weight Loss
FRIDAY, Oct. 6, 2023 -- Use of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss is associated with increased risks for pancreatitis, gastroparesis, and bowel obstruction compared with use of bupropion-naltrexone, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 6, 2023 Category: Pharmaceuticals Source Type: news

New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions
Medicines in the same class as popular weight-loss therapies Ozempic and Wegovy may carry an increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, Canadian researchers find. (Source: CBC | Health)
Source: CBC | Health - October 5, 2023 Category: Consumer Health News Tags: News/Health Source Type: news

Weight-Loss Drugs Come With Serious Side Effects, According to a New Study
There’s been a surge in demand for a class of diabetes drugs that are now popular for their serendipitous byproduct: weight loss. The drugs belong to a class called GLP-1 agonists and include semaglutide, the main ingredient in Ozempic, Wegovy, and Rybelsus; tirzepatide, which is found in Mounjaro; and liraglutide, used in Victoza and Saxenda. While effective in helping people with diabetes to lose about 15% of their body weight, these drugs are also linked to some risk of gastrointestinal side effects, including inflammation in the pancreas and obstructions of the digestive system. [time-brightcove not-tgx=”...
Source: TIME: Health - October 5, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news

Acute Pancreatitis May Progress to Chronic With Sustained Heavy Alcohol Use
WEDNESDAY, Sept. 20, 2023 -- Many patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression toward chronic pancreatitis, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news

Early Cholecystectomy Questioned for More Severe Acute Biliary Pancreatitis
(MedPage Today) -- Early -- rather than delayed -- cholecystectomy for adults hospitalized with more severe cases of acute biliary pancreatitis (ABP) was associated with worse postoperative outcomes, an international study found. Among 378... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - August 25, 2023 Category: Surgery Source Type: news

FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes
The U.S. Food and Drug Administration (FDA) is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 11, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news